| Efficacy of poly-lactic-co-glycolic acid micro-and nanoparticles of ciprofloxacin against bacterial biofilms N Thomas, C Thorn, K Richter, B Thierry, C Prestidge Journal of Pharmaceutical Sciences 105 (10), 3115-3122, 2016 | 53 | 2016 |
| Tobramycin Liquid Crystal Nanoparticles Eradicate Cystic Fibrosis‐Related Pseudomonas aeruginosa Biofilms CR Thorn, CS Carvalho‐Wodarz, JC Horstmann, CM Lehr, CA Prestidge, ... Small 17 (24), 2100531, 2021 | 45 | 2021 |
| Enhancing the therapeutic use of biofilm-dispersing enzymes with smart drug delivery systems CR Thorn, PL Howell, DJ Wozniak, CA Prestidge, N Thomas Advanced Drug Delivery Reviews 179, 113916, 2021 | 41 | 2021 |
| Nano-fats for bugs: The benefits of lipid nanoparticles for antimicrobial therapy CR Thorn, N Thomas, BJ Boyd, CA Prestidge Drug Delivery and Translational Research 11, 1598-1624, 2021 | 40 | 2021 |
| Bacterial lipase triggers the release of antibiotics from digestible liquid crystal nanoparticles CR Thorn, AJ Clulow, BJ Boyd, CA Prestidge, N Thomas Journal of controlled release 319, 168-182, 2020 | 40 | 2020 |
| Enzyme responsive copolymer micelles enhance the anti-biofilm efficacy of the antiseptic chlorhexidine YN Albayaty, N Thomas, M Jambhrunkar, M Al-Hawwas, A Kral, CR Thorn, ... International Journal of Pharmaceutics 566, 329-341, 2019 | 31 | 2019 |
| Protective liquid crystal nanoparticles for targeted delivery of PslG: a biofilm dispersing enzyme CR Thorn, D Raju, I Lacdao, S Gilbert, P Sivarajah, PL Howell, ... ACS Infectious Diseases 7 (8), 2102-2115, 2021 | 24 | 2021 |
| Testing of aerosolized ciprofloxacin nanocarriers on cystic fibrosis airway cells infected with P. aeruginosa biofilms J Juntke, X Murgia, N Günday Türeli, AE Türeli, CR Thorn, M Schneider, ... Drug delivery and translational research 11 (4), 1752-1765, 2021 | 20 | 2021 |
| Pseudomonas Infection Responsive Liquid Crystals for Glycoside Hydrolase and Antibiotic Combination CR Thorn, CA Prestidge, BJ Boyd, N Thomas ACS Applied Bio Materials 1 (2), 281-288, 2018 | 18 | 2018 |
| The journey of a lifetime—development of Pfizer’s COVID-19 vaccine CR Thorn, D Sharma, R Combs, S Bhujbal, J Romine, X Zheng, ... Current opinion in biotechnology 78, 102803, 2022 | 15 | 2022 |
| A Custom-Made Device for Reproducibly Depositing Pre-metered Doses of Nebulized Drugs on Pulmonary Cells in vitro JC Horstmann, CR Thorn, P Carius, F Graef, X Murgia, ... Frontiers in Bioengineering and Biotechnology 9, 643491, 2021 | 11 | 2021 |
| Liquid Crystal Nanoparticles Enhance Tobramycin Efficacy in a Murine Model of Pseudomonas aeruginosa Biofilm Wound Infection CR Thorn, A Wignall, Z Kopecki, A Kral, CA Prestidge, N Thomas ACS Infectious Diseases 8 (4), 841-854, 2022 | 9 | 2022 |
| Liquid crystal nanoparticle platform for increased efficacy of cationic antimicrobials against biofilm infections CR Thorn, Z Kopecki, A Wignall, A Kral, CA Prestidge, N Thomas Nanomedicine: Nanotechnology, Biology and Medicine 42, 102536, 2022 | 7 | 2022 |
| A Custom-Made Device for Reproducibly Depositing Pre-metered Doses of Nebulized Drugs on Pulmonary Cells. JC Horstmann, CR Thorn, P Carius, F Graef, X Murgia, ... Frontiers, 2021 | 1 | 2021 |
| Antibiotic resistance and tolerance: What can drug delivery do against this global threat? J Aparicio-Blanco, N Vishwakarma, CM Lehr, CA Prestidge, N Thomas, ... Drug Delivery and Translational Research, 1-10, 2024 | | 2024 |
| Antimicrobial compositions and methods of use C Thorn, N Thomas, C Prestidge US Patent App. 18/031,762, 2023 | | 2023 |
Clive PrestidgeProfessor, Co-Director Centre for Pharmaceutical Innovation,University of South AustraliaVerified email at unisa.edu.au
